. . . . . . . . . "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." . . . . . . "adults" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "LLnzan0O3NdZNEMUbCHoSNwtFKM03qeeYdp3EDotYgIVPvT8P6DgWRgglUKcRZtmA89mZgphmoW31aaSCWuHVjhMrgkIkwtc0h1vldDneaSb59cnXA9ZYadn6JtDLFW3hKa2YSAhue8QMQdfLHbGRDf//ZlCtbiybMVXdh/J+oM=" . . "2021-05-01T09:56:42.444+02:00"^^ . . . . .